US 12,275,767 B2
Chemigenetic calcium indicators
Eric R. Schreiter, Leesburg, VA (US); Luke D. Lavis, Ashburn, VA (US); Claire Deo, Heidelberg (DE); Hersh Bhargava, San Francisco, CA (US); and Ahmed Abdelfattah, Barrington, RI (US)
Assigned to HOWARD HUGHES MEDICAL INSTITUTE, Chevy Chase, MD (US)
Filed by HOWARD HUGHES MEDICAL INSTITUTE, Chevy Chase, MD (US)
Filed on Jun. 7, 2023, as Appl. No. 18/330,459.
Application 18/330,459 is a continuation of application No. 16/768,153, granted, now 11,708,397, previously published as PCT/US2018/068160, filed on Dec. 31, 2018.
Claims priority of provisional application 62/611,666, filed on Dec. 29, 2017.
Prior Publication US 2023/0416320 A1, Dec. 28, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 14/47 (2006.01); A61K 49/00 (2006.01); G01N 21/77 (2006.01); G01N 33/58 (2006.01); G01N 33/84 (2006.01)
CPC C07K 14/4728 (2013.01) [A61K 49/0004 (2013.01); A61K 49/0041 (2013.01); A61K 49/0056 (2013.01); G01N 21/77 (2013.01); G01N 33/582 (2013.01); G01N 33/84 (2013.01); C07K 2319/20 (2013.01); C07K 2319/60 (2013.01); G01N 2021/7786 (2013.01); G01N 2333/4727 (2013.01)] 13 Claims
OG exemplary drawing
 
1. A nucleic acid, comprising a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, 3, 5, 7, 9, 11, and 14.